0001209191-20-053152.txt : 20201002 0001209191-20-053152.hdr.sgml : 20201002 20201002163048 ACCESSION NUMBER: 0001209191-20-053152 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201001 FILED AS OF DATE: 20201002 DATE AS OF CHANGE: 20201002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Richards C Marc CENTRAL INDEX KEY: 0001468881 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12111 FILM NUMBER: 201220451 MAIL ADDRESS: STREET 1: 7315 WISCONSIN AVENUE STREET 2: SUITE 250-W CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDNAX, INC. CENTRAL INDEX KEY: 0000893949 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 263667538 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 BUSINESS PHONE: 9543840175 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 FORMER COMPANY: FORMER CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC DATE OF NAME CHANGE: 19950801 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-10-01 0 0000893949 MEDNAX, INC. MD 0001468881 Richards C Marc 1301 CONCORD TERRACE SUNRISE FL 33323 0 1 0 0 EVP, Chief Financial Officer Common Stock 23498 D Employee Stock Options (right to buy) 16.14 2021-09-26 2023-12-26 Common Stock 192400 D Represents shares of the Issuer's common stock ("Common Stock") granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "2008 Plan"). Such shares are fully vested but may not be transferred until the earlier of (i) September 26, 2025 and (ii) the date of the closing of a "Change in Control" of the Issuer (as defined in the 2008 Plan), subject to certain exceptions. Option to purchase shares of Common Stock granted pursuant to the 2008 Plan that vests as follows: (A) 61,500 shares are exercisable if and when the Common Stock price closes at $22 per share (or above) for any 40 consecutive trading days before September 26, 2023 ("Performance End Date"); (B) 63,500 shares are exercisable if and when the Common Stock price closes at $25 per share (or above) for any 40 consecutive trading days before the Performance End Date; and (C) 67,400 of the option shares are exercisable if and when the Common Stock price closes at $29 per share (or above) for any 40 consecutive trading days before the Performance End Date; provided, that no option shares will vest prior to September 26, 2021. Exhibit 24 - Power of Attorney /s/ Dominic J. Andreano, Attorney-in-Fact 2020-10-02 EX-24.1 2 attachment1.htm EX-24.1 DOCUMENT

POWER OF ATTORNEY
For Executing Forms 3, 4, and 5

  Know all men by these presents, that the undersigned hereby appoints
Dominic J. Andreano with full power of substitution, the true and lawful
attorney-in-fact to:

(1)	execute for and on behalf of the undersigned SEC Forms 3, 4, and 5 relating
to the undersigned's interest in the Company's securities, in accordance with
Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules
thereunder;

(2)	do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete the execution of any such Form 3, 4,
or 5 and the timely filing of such form with the United States Securities and
Exchange Commission and any other appropriate authority; and

(3)	take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of the attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by the attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as the attorney-in-fact may approve in his
discretion.

  The undersigned hereby grants to the above attorney-in-fact full power and
authority to do and perform all and every act and thing whatsoever requisite,
necessary and proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact,
shall lawfully do or cause to be done by virtue of this Power of Attorney and
the rights and powers herein granted.  The undersigned acknowledges that the
above attorney-in-fact, in serving in such capacity at the request of the
undersigned, is not assuming any of the undersigned's responsibilities to comply
with Sections 13(d) or 16 of the Securities Exchange Act of 1937.

  The authority of Dominic J. Andreano under this Power of Attorney shall
continue until the undersigned is no longer required to file Forms 3, 4, or 5
with regard to the undersigned's ownership of or transactions in securities of
the Company, unless earlier revoked in writing.

  IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 28th day of September 2020.


                    /s/ C. Marc Richards
                    C.  Marc Richards